AU · rank #1 · 2026-10-23
SNT
GPW · PLN · $734M (USD)
The exact numbers the algorithm saw.
| Composite score Z-score blend of all factors below. | 0.912 |
|---|---|
| EPS revisions (30d) Change in consensus EPS estimate over the past 30 days ($/share). | +$2.35 |
| Net revisions (30d) Number of analysts revising upward minus downward. | 1 |
| Insider signal (90d) | — |
| Analyst upside Consensus target $373.00 | +11.0% |
| Momentum acceleration 3-month minus 12-month momentum. | -15.42% |
| Analyst rating 5 = Strong Buy, 1 = Strong Sell. | 4.40 |
| Gross margin TTM | +35.1% |
| 52w high | $398.40 |
| Market cap (USD) | $734M |
The AI research card
Independent qualitative review of each pick before the order is placed. On the rare day the research service is unavailable, the paper book trades on the quant ranking alone and no card appears here.
Summary
Synektik S.A. is the sole regional distributor, installer, and maintenance provider for Intuitive Surgical's da Vinci robotic surgery platforms and associated consumables across Poland, the Czech Republic, Slovakia, the Baltic states, and Ukraine.
Rationale
The analyst upside signal is validated by 100% positive 30-day EPS revisions and roughly 100% year-over-year revenue growth, driven by accelerating da Vinci installations and high-margin recurring consumables demand.
Material risks
- 1Potential loss or non-renewal of Intuitive Surgical's sole-distributor contract after December 2029, or a strategic shift by Intuitive toward direct commercialization in CEE markets.
- 2Reliance on Polish and regional public-hospital procurement budgets and variable tender timelines, which can create volatility in booked forward order backlogs.
AI verdict council
Each pick is reviewed independently by 3 models before any order. 2 of 3 voted to proceed.